Omar ME et al found a significantly lower total antioxidant capacity in breast cancer patients versus the healthy controls and Panis C et al has found a significantly lower CAT, SOD and GSH activity in the breast cancer patients when compared to the control group. This evidence concerns the gene CAT and breast carcinoma.